Literature DB >> 8403498

Regulation of resistance against adjuvant arthritis in the Fisher rat.

A G van de Langerijt1, P L van Lent, A R Hermus, L B van de Putte, W B van den Berg.   

Abstract

Inbred female Lewis (LEW/N) rats develop a severe chronic arthritis in the adjuvant arthritis (AA) model, histocompatible Fisher (F344/N) rats are resistant and germ-free Fishers (GF F344) are again susceptible. In this study we show that the F344 rat can become susceptible to AA, using Mycobacterium tuberculosis (M.tb.) in the powerful adjuvant paraffin oil, instead of mineral oil (Freund's incomplete adjuvant (FIA)). This indicates that the F344 rat does not lack T effector cells. To examine further mechanisms responsible for suppression, we determined the level of plasma corticosterone in response to IL-1 alpha in Lewis, F344 and GF F344 rats. IL-1 alpha induced only low amounts of corticosterone in Lewis rats, but high amounts in both F344 and GF F344 rats. The GF F344 rats are susceptible to AA, but the severity of the disease is reduced compared with Lewis rats. This indicates that corticosterone may be an important mechanism to suppress disease development, but not the only mechanism. In addition we investigated whether T suppressor cells play a role in the resistance of the F344 strain. This was performed by pretreating the animals with the immunomodulating drugs cyclophosphamide (Cy) and cyclosporin A (CsA). We were unable to make the F344 rat susceptible to AA, indicating that active suppression does not play a role in the induction phase of arthritis. This finding is confirmed in adoptive transfer experiments of AA from Lewis to F344 rats. Our data suggest the lack of a strong pre-existing suppression in the F344 rats, and indicate that suppression is generated upon bacterial challenge. Whether suppression is overruled probably depends on the power of adjuvants used and potential control by corticosteroids.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8403498      PMCID: PMC1534364          DOI: 10.1111/j.1365-2249.1993.tb05993.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  38 in total

1.  The effects of cyclosporin A on the induction, expression and regulation of the immune response to herpes simplex virus.

Authors:  D M Altmann; W A Blyth
Journal:  Clin Exp Immunol       Date:  1985-01       Impact factor: 4.330

2.  Long-term depletion of CD8+ T cells in vivo in the rat: no observed role for CD8+ (cytotoxic/suppressor) cells in the immunoregulation of experimental allergic encephalomyelitis.

Authors:  J D Sedgwick
Journal:  Eur J Immunol       Date:  1988-04       Impact factor: 5.532

3.  A comparison of immunosuppressive and anti-inflammatory agents in the rat.

Authors:  H L Currey
Journal:  Clin Exp Immunol       Date:  1971-12       Impact factor: 4.330

4.  The cellular basis of adjuvant arthritis. I. Enhancement of cell-mediated passive transfer by concanavalin A and by immunosuppressive pretreatment of the recipient.

Authors:  J D Taurog; G P Sandberg; M L Mahowald
Journal:  Cell Immunol       Date:  1983-02-01       Impact factor: 4.868

5.  Low-dose cyclosporin A induces relapsing remitting experimental allergic encephalomyelitis in the Lewis rat.

Authors:  C H Polman; I Matthaei; C J de Groot; J C Koetsier; T Sminia; C D Dijkstra
Journal:  J Neuroimmunol       Date:  1988-02       Impact factor: 3.478

6.  Chronic stimulation of the pituitary-adrenal axis in rats by interleukin-1 beta infusion: in vivo and in vitro studies.

Authors:  C G Sweep; M J van der Meer; A R Hermus; A G Smals; J W van der Meer; G J Pesman; S J Willemsen; T J Benraad; P W Kloppenborg
Journal:  Endocrinology       Date:  1992-03       Impact factor: 4.736

7.  Strain and sex variation in the susceptibility to streptococcal cell wall-induced polyarthritis in the rat.

Authors:  R L Wilder; G B Calandra; A J Garvin; K D Wright; C T Hansen
Journal:  Arthritis Rheum       Date:  1982-09

8.  A mycobacterial 65-kD heat shock protein induces antigen-specific suppression of adjuvant arthritis, but is not itself arthritogenic.

Authors:  M E Billingham; S Carney; R Butler; M J Colston
Journal:  J Exp Med       Date:  1990-01-01       Impact factor: 14.307

9.  Augmentation of delayed-type hypersensitivity by doses of cyclophosphamide which do not affect antibody responses.

Authors:  P W Askenase; B J Hayden; R K Gershon
Journal:  J Exp Med       Date:  1975-03-01       Impact factor: 14.307

10.  Arthritis in rats after systemic injection of streptococcal cells or cell walls.

Authors:  W J Cromartie; J G Craddock; J H Schwab; S K Anderle; C H Yang
Journal:  J Exp Med       Date:  1977-12-01       Impact factor: 14.307

View more
  4 in total

1.  A role for mast cells in the development of adjuvant-induced vasculitis and arthritis.

Authors:  B Johnston; A R Burns; P Kubes
Journal:  Am J Pathol       Date:  1998-02       Impact factor: 4.307

2.  Susceptibility to adjuvant arthritis: relative importance of adrenal activity and bacterial flora.

Authors:  A G van de Langerijt; P L van Lent; A R Hermus; C G Sweep; A R Cools; W B van den Berg
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

Review 3.  The determinants of susceptibility/resistance to adjuvant arthritis in rats.

Authors:  Eugene Y Kim; Kamal D Moudgil
Journal:  Arthritis Res Ther       Date:  2009-08-07       Impact factor: 5.156

Review 4.  Microbial considerations in genetically engineered mouse research.

Authors:  Craig L Franklin
Journal:  ILAR J       Date:  2006
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.